Cerebral reactivity in migraine patients measured with functional near-infrared spectroscopy
Pourshoghi A, Danesh A, Tabby DS, Grothusen J, Pourrezaei K, Eur J Med Res, 1/1/2015Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomized, double-blind, placebo-controlled, phase 3 trial
Confavreux C for the TOWER Trial Group (Tabby DS, contributor), Lancet Neurol, 1/22/2014Headache in Multiple Sclerosis
Tabby DS, POMA Journal, 1/1/2014
